A system for grabbing and filling pills into a blister pack is provided and associated corresponding method. The system includes a vacuum pill-manipulator provided with prongs having holes at their tip to retain pills. The vacuum pill-manipulator is configured to transition from a pill-retaining configuration where suction is applied at the tip of each prong to hold the pills during movement, to a pill-releasing configuration where suction is released to drop the pills in corresponding pill-chambers. A robotized arm is provided with the vacuum pill-manipulator, and is controllable to: move the vacuum pill-manipulator from a pill-container rack, for grabbing a pill-container, to a pill-container retaining station, to suction pills at the tips of the prongs; and move, in the pill-retaining configuration, the vacuum pill-manipulator to the blister pack location, and position the vacuum pill-manipulator to align the tip of each prong with the corresponding pill-chamber for the pill-releasing configuration.

Approaches for use in making a lid for a blister package include forming a continuous pattern of electrically conductive wire on an adhesive surface of a substrate. The continuous pattern has a plurality of detector segments, and each detector segment has an outer connector portion and an inner connector portion. The outer connector portion and the inner connector portion of each detector segment are adjacent to one another, and pairs of successive first and second detector segments of the plurality of detector segments are connected by the inner connector portion of the first detector segment and the outer connector portion of the second detector segment. The forming includes forming an arced segment between the inner connector portion of the first detector segment and the outer connector portion of the second detector segment.

The invention relates to crystalline forms of Alpha-1062 gluconate. In one aspect, the invention relates to a crystalline solid form of Alpha-1062 gluconate (Form A), wherein said crystalline form has prominent peaks at 3.61, 10.98, 14.41 and 18.44 degrees 2-theta (±0.2) in a powder X-ray diffraction pattern. The invention further relates to methods for manufacturing crystalline forms and compositions comprising said crystalline forms.

A method of dosing a psychedelic that avoids the side effects of hallucinations and perceptual disturbances by administering the psychedelic to an individual in a titrating dosing regimen and reducing side effects of hallucinations and perceptual disturbances. A kit for administering a titrating dosing regimen of a psychedelic, including a pharmaceutically effective amount of the psychedelic in dosage forms separated in packaging according to dose and time of administration in a titrating dosing regimen, and instructions for use. A method of treating an individual with psychedelics, by administering the psychedelic to the individual having a condition or disease in a titrating dosing regimen and reducing side effects of hallucinations and perceptual disturbances during treatment.

A blister pack having a backing having a first side and an opposing second side. Each of the first and second side is flat or planar. The blister pack can also include a cover having a first side and an opposing second side. At least a portion of the second side of the cover is adhered to the first side of the backing to form a sealed package for containing product. The cover can include at least one blister. The blister pack can also include an active member positioned within each blister. Each active member can be in the form of a ring with an opening extending therethrough or a depression formed therein.

Medication magazines including one or more compartments that hold respective sleeves of medication, as well as a respective blister card, are provided. The blister card(s) include blisters of medication, and the blister sleeve(s) include openings designed to align with the blisters of the blister card(s). The removal of medication from each blister may be automatically detected and digitally recorded, along with the time and the individual who removed the medication. In addition to permitting alignment of each blister on the blister card, the openings on the sleeve also permit the ejection of the medicine through the openings without being removed from the sleeve. Intelligent medication management systems configured to provide end-to-end management and monitoring for patient dosing regimens are also provided.

The present disclosure relates to wireless medication blister pack assembly and to a blister pack attachment to be secured to a blister pack assembly. The attachment an electronic card housing for receiving an electronic card which includes electronic components such as card connectors, and a locking system which is configurable between a locked configuration and a releasing configuration. In the locked configuration, the blister pack assembly and the electronic card are connected, with sheet connectors provided on the blister pack assembly and the card connectors being in electronic communication. Such electronic communication allows the electronic components to detect whether a given blister has been detached from the blister pack assembly. In the releasing configuration, the electronic card and the blister pack assembly can be removed from the blister pack attachment, so as to allow the electronic card to be reused with a replacement blister pack assembly.

Systems and containers for organizing and administering an oral immunotherapy regimen to a patient are disclosed herein. One aspect of the present technology is directed systems for efficiently and safely identifying pre-packaged dose units to administer to a patient undergoing oral immunotherapy. Further aspects of the present technology are directed to reducing medical staff dosing errors when administering an oral immunotherapy regimen. In one embodiment, the system includes a plurality of dosage containers, wherein each dosage container includes dosage identification characteristics corresponding to dosage of an oral immunotherapy composition. Further aspects of the present technology are directed to methods of dispensing an oral immunotherapy composition to a patient in a manner that mitigates the risk of errors in oral immunotherapy dose administration.

A system for assisting a manual filling of at least two dose packs laid on a support surface wherein each said dose pack has receptacles adapted to receive medication items based on dose pack prescription profiles. The system generally has a dose pack medication localizer for determining a location of each receptacle of each said dose pack, and for identifying medication items required in each said receptacle using the dose pack prescription profiles; a medication grouper for grouping, for each of the medication items of the dose pack prescription profiles of all of the dose packs, the locations of each said receptacle to be filled with a corresponding one of the medication items; a distribution matrix generator for generating a distribution sequence for filling the dose packs using each one of said grouping; and an output for producing a visual representation of the distribution sequence.

The device serves for the controlled conveying of a cable. The device has a housing, having a cover plate, on which are externally mounted a drive wheel and contact wheel which can be radially pressed onto the drive wheel, between which the cable can be clamped. The cable can be conveyed by means of the drive wheel being driven by a drive unit in the interior of the housing. The rotational motion of the drive wheel is guided through a stationary light barrier by means of a counting disc, running synchronously therewith and having radial slots or holes in the circumferential area, for determining the motion and rotational speed of the drive wheel. The cover plate and the housing can be sterilized. The drive unit in the interior of the housing is not sterilizable, yet is completely enclosed by the sterilized housing and cover plate.